Zoledronic (zoledronic): Reviews and patient testimonials
Back to the list of medications
Medication indications
Zoledronic acid 4 mg / 5 ml concentrate for solution for infusion
• Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.
• Treatment of adult patients with tumour-induced hypercalcaemia (TIH).
Zoledronic Acid 4 mg/100 ml solution for infusion
− Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.− Treatment of adult patients with tumour-induced hypercalcaemia (TIH).Zoledronic acid 4 mg/100 ml Solution for Infusion
- Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.
- Treatment of adult patients with tumour-induced hypercalcaemia (TIH).
Zoledronic acid 5 mg solution for infusion
Treatment of osteoporosis
- in post-menopausal women
- in adult men
at increased risk of fracture, including those with a recent low-trauma hip fracture.
Treatment of osteoporosis associated with long-term systemic glucocorticoid therapy
- in post-menopausal women
- in adult men
at increased risk of fracture.
Treatment of Paget's disease of the bone in adults.
Zoledronic Acid 5 mg/ 100 ml solution for infusion
Treatment of osteoporosis
in post-menopausal women
in adult men
at increased risk of fracture, including those with a recent low-trauma hip fracture.
Treatment of osteoporosis associated with long-term systemic glucocorticoid therapy
in post-menopausal women
in adult men
at increased risk of fracture.
Treatment of Paget's disease of the bone in adults.
Zoledronic Acid 5 mg/100ml solution for infusion
Treatment of osteoporosis
• in post-menopausal women
• in adult men
at increased risk of fracture, including those with a recent low-trauma hip fracture.
Treatment of osteoporosis associated with long-term systemic glucocorticoid therapy
• in post-menopausal women
• in adult men
at increased risk of fracture.
Treatment of Paget's disease of the bone in adults.
Zoledronic Acid Accord 4 mg/5 ml concentrate for solution for infusion
- Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.- Treatment of adult patients with tumour-induced hypercalcaemia (TIH).Zoledronic acid Actavis 4 mg/5 ml concentrate for solution for infusion
- Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.- Treatment of adult patients with tumour-induced hypercalcaemia (TIH).Zoledronic acid Dr. Reddys 4 mg/5 ml concentrate for solution for infusion
- Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.
- Treatment of adult patients with tumour-induced hypercalcaemia (TIH).
Zoledronic acid Dr. Reddys 5 mg/100 ml solution for infusion
Treatment of osteoporosis
• in post-menopausal women
• in adult men
at increased risk of fracture, including those with a recent low trauma hip fracture.
Treatment of osteoporosis associated with long term systemic glucocorticoid therapy
• in post-menopausal women
• in adult men
at increased risk of fracture.
Treatment of Paget's disease of the bone in adults.
Zoledronic Acid Hospira 4 mg/100 ml solution for infusion
- Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.
- Treatment of adult patients with tumour-induced hypercalcaemia (TIH).
Zoledronic Acid Hospira 4 mg/5 ml concentrate for solution for infusion
- Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.
- Treatment of adult patients with tumour-induced hypercalcaemia (TIH).
Zoledronic Acid Hospira 5 mg/100 ml solution for infusion
Treatment of Paget's disease of the bone in adults.
zoledronic acid medac 4mg/100ml solution for infusion
- Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.
- Treatment of adult patients with tumour-induced hypercalcaemia (TIH).
zoledronic acid medac 4mg/5ml concentrate for solution for infusion
- Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.
- Treatment of adult patients with tumour-induced hypercalcaemia (TIH).
Zoledronic acid Mylan 4 mg/5 ml concentrate for solution for infusion
- Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.
- Treatment of adult patients with tumour-induced hypercalcaemia (TIH).
Route of administration: Injectable
Molecule: zoledronic
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.